Introduction
Therapeutic gene transfer to self-renewing somatic tissues has relied on viral vectors. As a result of their ability to achieve stable genomic integration into tissue stem cells, retroviruses have served as a mainstay of such efforts. Retroviral vectors are capable of targeting somatic stem cells and achieving durable gene delivery through multiple turnover cycles in tissues that undergo continual regeneration such as epidermis.
1,2 Retroviral gene transfer, however, suffers from the production, cost, storage and biosafety issues common to all viral vectors. While plasmid vectors are free of many of these drawbacks, they have been limited by transient episomal expression insufficient to support durable phenotypic reversion in skin and other tissues. [3] [4] [5] Limitations of current viral and nonviral approaches to stable somatic tissue gene transfer have stimulated the search for nonviral approaches to stably integrate therapeutic genes. Among such approaches is plasmidbased gene transfer mediated by the Sleeping Beauty (SB) synthetic transposable element. [6] [7] [8] SB is an ancestral fish member of the Tc1/mariner family. 9 SB transposition integrates incoming DNA into the genome using a 'cutand-paste' mechanism requiring short inverted repeat (IR) sequences flanking the insert and the SB transposase protein. 10 SB transposase has been shown to facilitate gene integration into mammalian cell lines and murine liver sufficient to support long-term gene delivery. 6, 7 In spite of these attractive features, transposon-mediated gene transfer has not yet been reported capable of achieving stable genetic correction of human tissue from patients with characterized genetic disorders. Severe junctional epidermolysis bullosa (JEB) is a genodermatosis characterized clinically by widespread epithelial fragility and blistering that commonly leads to death in the first years of life.
11 Mutations in a number of genes can underly lethal JEB, however, the LAMB3 gene that encodes the laminin b3 subunit of laminin 5 is the most commonly affected. 11, 12 Laminin 5 is a heterotrimer comprised of laminin a3, b3 and g2 chains and serves a major constituent of the cutaneous basement membrane zone. It interacts physically with a6b4 integrin on the basal surface of epidermal keratinocytes to promote hemidesmosome formation as well as with Type VII collagen in dermal anchoring fibrils to enhance basement membrane zone integrity. 13, 14 In facilitating these processes, laminin 5 plays a nonredundant role in epidermal-dermal adhesion. 12, 15 Recently, Moloney murine leukemia-based amphotropic retroviruses have been used to transduce successfully LAMB3 mutant stem cells from JEB patient epidermis. 2 While efficient, durable and capable of normalizing laminin 5 protein expression and hallmark JEB disease features, this approach suffers from limitations that include biosafety concerns as well as the expense and regulatory hurdles of viral gene transfer. Extending such corrective gene delivery to self-renewing human tissues towards widespread clinical application will benefit from nonviral approaches to durable gene transfer.
Here we demonstrate stable restoration of laminin 5 protein expression to human epidermal tissue from a series of six unrelated JEB patients using the SB transposon. Gene transfer integrated the LAMB3 cDNA into genomes of epidermal stem cell holoclones in vitro. Following short-term enrichment for corrected cells in culture, laminin 5 expressing JEB keratinocytes were used to regenerate human skin on immune-deficient mice. JEB skin regenerated from these cells displayed correction of key JEB disease characteristics, including reexpression of laminin 5 protein, restored hemidesmosome formation and lack of epidermal-dermal blistering. These data demonstrate that transposition-based gene transfer offers a feasible approach to stable gene delivery to self-renewing human tissues in the treatment of genetic diseases of skin and other tissues.
Results
Gene delivery to primary keratinocytes using the SB transposase Nonviral plasmid-based vectors are free of many of the disadvantages that constrain viral vectors; however, conventional plasmids exist as episomes and thus achieve only transient gene transfer because such extragenomic DNA is unstable. To achieve stable plasmid-based nonviral gene transfer in JEB, we used an approach to permanent gene integration based on the SB ancestral fish transposon. An SB IR-flanked laminin b3 expression plasmid was constructed in which gene expression is directed by the CMV IE promoter driving both laminin b3 expression and the blastocidin resistance gene (pLAMB3) as well as lacZ marker control (pLacZ) (Figure 1 ). The CMV promoter used supports durable gene transfer to human epidermis and is active throughout the epidermis.
1,2,16 SB transposition has been shown to act with varying efficacy depending on the target cell type, 6 thus we first tested its functionality in primary cells of human skin. Normal keratinocytes were transfected with pLacZ with and without CMV-driven expression vectors encoding SB and an inactive SB mutant (mSB). 7 At 2 days after transfection, equivalent proportions of cells in each group were X-gal(+) (4271.3, 4170.8 and 4372.3 for pLacZ alone, pLacZ/SB and pLacZ/mSB, respectively). After 2 weeks of growth without selection, cells were subjected to X-gal staining to examine plasmid retention. As recently reported, both corrected and uncorrected JEB keratinocytes display normal growth kinetics when plated on extracellular matrix. 17 After selection, cells cotransfected with pLacZ and wild-type SB expression plasmids displayed 5574.5-fold more X-gal(+) cells (Figure 1b , c) with a total of 17.27% of unselected cells X-gal(+). The percentage of Xgal(+) in cells receiving either no SB or inactive mutant SB was 0.3 and 0.4%, respectively. Thus, SB transposase enhances the durability of gene delivery to primary human keratinocytes in culture.
Restoration of laminin 5 protein expression in epidermal holoclones
We next wished to extend findings with marker gene delivery in normal keratinocytes to LAMB3 gene transfer in JEB. Primary keratinocytes from six previously characterized unrelated JEB patients with LAMB3 mutations and absent laminin 5 protein expression 2 were transfected with pLAMB3 and either SB or mSB expression plasmids. After 10 days of growth without selection following transfection, JEB cells receiving wildtype transposase and pLAMB3 plasmids (JEB(+)) displayed restored expression of full-length laminin b3 protein; expression was undetectable in control JEB cells ( Figure 2a ). To enrich the percentage of transfected cells in the bulk population, a parallel set of cells were exposed to short-term drug selection for 10 days following transfection. Consistent with prior observations, 16 blastocidin selection exerted no effects on keratinocyte morphology or subsequent proliferative ability. At this timepoint, 499% of cells in JEB(+) bulk populations demonstrated normalized cellular expression of laminin b3 protein by immunohistochemistry ( Figure 2b ). To examine if transposase gene delivery targets epidermal stem cells, keratinocytes enriched with short-term selection were plated at limiting dilution and holoclones 18 were isolated based on high proliferative capacity as previously described. 2, 19 Plasmid rescue was performed for 10 independently isolated holoclones. Sequence analysis of recovered transposon integrants showed SB-mediated transposition into TA dinucleotides in multiple different chromosomes ( Table 1) . None of these integrations appeared to reside within known intragenic sequences. These findings indicate that transposon-mediated gene transfer stably integrates delivered 
Laminin 5 gene delivery in JEB patient skin tissue in vivo
We next examined if transposon-based LAMB3 gene transfer to epidermal holoclones corrected hallmark JEB disease features. Following 10 days selection enrichment in culture, pLAMB3-transfected cells were utilized to regenerate human skin on CB.17 scid/scid immunedeficient mice in an approach that accurately recapitulates the histologic, protein expression and functional features of the individual donor, including pathologic aspects of specific genetic skin diseases. 2, [20] [21] [22] [23] Similar to the donor skin on each of the series of JEB patients, skin regenerated from pLacZ transfected JEB skin demonstrated separation at the dermal-epidermal junction and no detectable laminin 5 expression was observed ( Figure 3 ). In contrast, skin tissue regenerated from pLAMB3-transfected JEB cells from the same patients exhibited normal histology and an intact dermalepidermal junction (Figure 3a) . Moreover, laminin 5 was correctly distributed to the junction in a polarized manner indistinguishable from normal tissue (Figure 3b ). While quantitating laminin 5 protein levels in vivo is difficult because of the insoluble nature of the protein, laminin 5 immunostaining intensity was similar to normal human controls, suggesting that protein restoration occurred in the physiologic range. In agreement with the observed targeting of holoclones, laminin 5 expression was stable, lasting for the 16-week duration of the experiment through multiple epidermal turnover cycles, defined previously in regenerated human skin as 3-4 weeks in length.
2 Thus, transposon-based gene transfer supports durable gene delivery and normalized laminin 5 protein expression to regenerated human JEB epidermis in vivo.
The ultrastructural consequences of laminin 5 absence in mice and humans include an absence of hemidesmosomes in the cutaneous basement membrane zone. 11, 12 To examine if hemidesmosome formation was restored by expressed laminin 5 in regenerated JEB patient skin, we undertook immunoelectron microscopy. While uncorrected JEB skin lacked hemidesmosomes, these structures were restored in pLAMB3-engineered JEB skin ( Figure 4 ). Immunogold labeling using species-specific antibodies to human laminin 5 labeled anchoring filaments extending inward from hemidesmosome structures and confirmed their human origin (Figure 4 ), confirming restoration of the major ultrastructural deficit in JEB.
Discussion
Our studies demonstrate that nonviral transposonmediated gene delivery enables genetic correction of self-renewing human tissue from a life-threatening inherited skin disease. Prior approaches restored expression of a number of genes to epidermal cells in JEB and other skin diseases in vitro 24, 25 and in regenerated tissue in vivo;
2,21-23 however, they relied on amphotropic retroviruses with all their attendant drawbacks. In the plasmid-based approach presented here, functional SB transposase is required for sustained corrective gene delivery because a nonfunctional mutant failed to maintain gene transfer, even in vitro. Stable gene delivery was achieved with integration of laminin b3 encoding sequences into genomes of holoclones of high proliferative capacity. Similar to prior viral studies with a promoter active in all epidermal layers, we found that the CMV promoter employed in the pLAMB3 plasmid sufficed to support correctly polarized laminin 5 protein expression. Thus, although vectors targeting epidermal regions using layer-specific promoters have been developed, 26 they have proven unnecessary for properly restored protein distribution in both the current study and in the other epidermal genodermatoses corrected in vivo to date. 2, [21] [22] [23] This finding points to a post-transcriptional process, potentially facilitated by physical interactions with other laminin 5 chains and corresponding ligands, such as a6b4 integrin and Type VII collagen, that may direct correct laminin b3 distribution. 13, 14 Normalization of JEB skin tissue occurred at the levels of tissue laminin 5 expression and hemidesmosome formation. The presence of hemidesmosomes, the restored expression of laminin 5 and the absence of junctional blistering are strong indicators that tissue cohesion was normalized. These findings suggest that transposase-mediated gene transfer will support efforts directed at stable genetic correction in JEB patients. 
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The approach used here relies upon a specific series of steps to achieve phenotypic correction of JEB skin. First, plasmids were introduced into primary JEB patient keratinocytes at 440% efficiency. Transfected cells were then enriched using a short course of drug selection, with integration driven by SB transposase coexpression then used to regenerate human skin. The fact that all studied holoclones of high proliferative capacity demonstrated SB-mediated transposition of laminin b3 encoding sequence confirmed that this corrected population contains the holoclone cells sufficient to sustain epidermal self-renewal. 2, 27 Consistent with this, laminin 5 protein expression was maintained through multiple epidermal turnover cycles in vivo. For human epidermis, such self-renewal turnover cycles have been defined as of 3-4 weeks in duration. 2 This approach thus avoids pitfalls of prior plasmid-based efforts in keratinocytes where plasmid-driven expression is commonly lost by 3-5 days 3, 5 and where long-term drug selection triggers differentiation with loss of proliferative capacity. 28 Through expeditious production of genetically corrected holoclone-containing cell populations, the data described here afford a practical approach to nonviral gene therapy to self-renewing tissues in humans. Transposon-based plasmid integration thus provides the ability to achieve stable nonviral gene transfer through genomic integration in tissue stem cells and offers a rational alternative to current viral approaches.
Materials and methods

JEB patients and cell growth
Primary epidermal cells from laminin 5-deficient JEB patients meeting clinical, immunohistological, ultrastructural and genetic criteria for the disease were selected from the National Epidermolysis Bullosa Registry site at Stanford University. 2 Patients studied had confirmed LAMB3 gene mutations and an absence of laminin 5 protein in skin, as defined by immunochemistry. Normal control keratinocytes were obtained from unrelated individuals unaffected by EB. Cells were isolated and grown in culture in 50% serum-free medium (GIBCO/ BRL) and 50% medium154 (Cascade Biologics) as described. 2 For holoclone characterization, cells were plated at limiting dilution and single holoclone colonies of high proliferative capacity 18 measuring 45 mm in diameter were isolated as described 2, 19 and used for genomic integration studies.
Vectors and gene transfer
Plasmids: A BglII/DrdI fragment encoding LAMB3/LacZ IRES and Blastocidin resistance was cloned as a BglII/ DrdI (blunt) fragment into the BglII/NheI (blunt) sites of pTMCS containing the inverted repeats 5IR and 3IR, producing the vector pTMCS LAMB3 (pLAMB3) and pTMCS LacZ (pLacZ). A plasmid containing a neomycin-phosphotransferase (neo) and kanamycin expression cassette flanked by SB inverted repeats (pTnori) was used for transposon rescue from keratinocyte genomes. Cells were transfected with pLAMB3 or with pLacZ and CMV-driven expression vectors 7 for either with wildtype transposase (pCMV-SB; SB) or inactive mutant transposase (pCMV-mSB; mSB) using modified polybrene shock as described. 29 Cells were either grown without selection for assessment of sustained gene expression or subjected to 10 days of blasticidin selection (4mg/ml). Gene transfer efficiency was verified by immunofluorescence microscopy and immunoblot analysis.
Plasmid rescue and sequence analysis of integrants
Human keratinocytes were transfected with pTnori and a helper plasmid expressing either functional (SB) or nonfunctional (mSB) transposase. After 10 days selection, keratinocyte colonies were trypsinized and subcloned at limiting dilution to obtain highly proliferative holoclones. 2, 19 Genomic DNA was extracted and digested with NheI, SpeI and XbaI. Each of these endonucleases produces compatible cohesive ends and does not cut within the transposon or the plasmid encoded ampicillin gene. 7 Ligations were performed with T4 DNA ligase under dilute conditions, then transformed into DH10B electrocompetent cells followed by replica plating on LB agar containing ampicillin (100 mg/ml) or kanamycin (30 mg/ml). Transposon DNA reisolated from Amp R / Kan R bacteria was analyzed by HindIII digestion and gel electroporesis. The DNA flanking 5 0 and 3 0 terminal transposon repeats was sequenced using primers IR-1 (5 0 -AGATGTCCTAACTGACTTGCC-3 0 ) and IR-2 (5 0 -GTGGTGATCCTAACTGA CCTT-3 0 ), respectively.
Animal studies
JEB patient and normal control skin was regenerated using primary keratinocytes on CB.17 scid/scid mice using porcine dermal substrate to avoid immune crossreactivity of antibodies to laminin 5 as described. 2 The duration of the in vivo experiment was 16 weeks; at 4, 8 and 16 weeks postgrafting, human skin tissue was excised and analyzed.
Analysis of protein expression and tissue ultrastructure
Polyclonal antibodies to human laminin 5 and the K140 monoclonal antibody to human laminin b3 (gift of MP Marinkovich) 30 were used to verify expression of both the laminin 5 trimer and full-length laminin b3 via immunoblot analysis. Keratinocyte extracts were prepared and 20 mg of extract protein electrophoresed on a Figure 4 Restoration of hemidesmosome formation to JEB skin tissue. Immunoelectron microscopy of human skin regenerated from primary JEB patient keratinocytes transfected with LacZ control (JEB(À)), pLAMB3/SB (JEB(+)) as well as primary cells from normal patients (NL). Note the absence of hemidesmosomes in uncorrected tissue and the restoration of these structures in JEB(+) tissue similar to normal control; black dots represent immunogold labeling of laminin 5 b3 protein in anchoring filaments using human species-specific antibodies to laminin 5 b3 (E¼epidermal cell; D¼dermis). 
Homology
Plasmid rescue from 10 JEB(+) keratinocyte holoclones. Sequence, chromosomal location of integration site and degree of sequence homology to genomic sequence are shown.
Nonviral laminin 5 genetic correction S Ortiz-Urda et al 6% polyacrylamide gel with blots incubated simultaneously with antibodies to BRG1 control 31 for loading, extract quality and transfer efficiency. For immunohistochemistry, 5 mm skin cryosections were fixed and immunostained with laminin 5 antibodies as well as human species-specific antibodies to involucrin (Covance). Sections were also analyzed by immunogold electron microscopy to assess human anchoring filament formation and hemidesomosome ultrastructure.
